MedPath

TEVA-MOCLOBEMIDE

TEVA-MOCLOBEMIDE

Discontinued
DIN Number

02239746

Drug Class

Human

Market Date

May 20, 1999

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02239746
AIG Number0122658001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N06AG02 MOCLOBEMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:16.04.12
Health Canada Classification

ACTIVE INGREDIENTS (1)

MOCLOBEMIDEActive
Strength: 100 MG
Monograph: MOCLOBEMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.